Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Healthcare providers must tell patients about these risks and benefits
This decline is closely associated with many of the metabolic changes people experience as they grow older, including shifts in body composition, reduced energy, and decreased insulin sensitivity
no Phase II or III trials published Most common AOD-9604 side effect / Injection-site reaction (redness, swelling) Most common reported MOTS-c side effect / Transient flushing and mild GI discomfort (anecdotal, not trial-confirmed) Growth hormone axis impact / AOD-9604 does not activate the GH receptor
Retatrutide, also known as LY3437943, is an investigational synthetic peptide
US$ 29.82
US$ 20.21
US$ 21.94
